Amyloid precursor protein and presenilin 1 interaction studied by FRET in human H4 cells

Annals of the New York Academy of Sciences

Volumn 1096, Issue , 2007, Pages 249-257

  Nizzari, Mario ^a   Venezia, Valentina ^a   Bianchini, Paolo ^a   Caorsi, Valentina ^a   Diaspro, Alberto ^a   Repetto, Emanuela ^a   Thellung, Stefano ^a   Corsaro, Alessandro ^a   Carlo, Pia ^a   Schettini, Gennaro ^a   Florio, Tullio ^a   Russo, Claudio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Centrosomes; Confocal microscopy; FRET; Presenilins

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

CELLULAR DISTRIBUTION; CENTROSOME; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; MICROTUBULE; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; ARTICLE; BIOSYNTHESIS; CHEMISTRY; FLUORESCENCE MICROSCOPY; INSTRUMENTATION; METABOLISM; METHODOLOGY; PROTEIN BINDING; TUMOR CELL LINE; ULTRASTRUCTURE;

AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE, TUMOR; CENTROSOME; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PRESENILIN-1; PROTEIN BINDING;

EID: 34247233223     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.091     Document Type: Conference Paper

References (22)

1. LIPPA, C.F., J.M. SWEARER, K.J. KANE, et al. 2000. Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann. Neurol. 48: 376-379.
2. GOLDE, T.E. & C.B. ECKMAN. 2003. Physiologic and pathologic events mediated by intramembranous and juxtamembranous proteolysis. Sci. STKE. 2003: RE4.
3. SELKOE, D.J. 2002. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J. Clin. Invest. 110: 1375-1381.
4. GOLDE, T.E. 2003. Alzheimer disease therapy: can the amyloid cascade be halted? J. Clin. Invest 111: 11-18.
5. PRASHER, V.P., M.J. FARRER, A.M. KESSLING, et al. 1998. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann. Neurol. 43: 380-383.
6. FLUHRER, R., G. MULTHAUP, A. SCHLICKSUPP, et al. 2003. Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation. J. Biol. Chem. 278: 5531-5538.
7. WALSH, D.M., J.V. FADEEVA, M.J. LAVOIE, et al. 2003. Gamma-Secretase cleavage and binding to FE65 regulate the nuclear translocation of the intracellular C-terminal domain (ICD) of the APP family of proteins. Biochemistry 42: 6664-6673.
8. GAO, Y. & S.W. PIMPLIKAR. 2001. The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl. Acad. Sci. USA 98: 14979-14984.
9. TANZI, R.E. & L. BERTRAM. 2005. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120: 545-555.
10. DE STROOPER, B. 2003. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38: 9-12.
11. HANSSON, C.A., S. FRYKMAN, M.R. FARMERY, et al. 2004. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J. Biol. Chem. 279: 51654-51660.
12. RAEMAEKERS, T., C. ESSELENS & W. ANNAERT. 2005. Presenilin 1: more than just gamma-secretase. Biochem. Soc. Trans. 33: 559-562.
13. LI, J., M. XU, H. ZHOU, et al. 1997. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90: 917-927.
14. KINOSHITA, A., C.M. WHELAN, C.J. SMITH, et al. 2002. Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J. Neurochem. 82: 839-847.
15. DELGEHYR, N., J. SILLIBOURNE & M. BORNENS. 2005. Microtubule nucleation and anchoring at the centrosome are independent processes linked by ninein function. J. Cell Sci. 118: 1565-1575.
16. DOXSEY, S., W. ZIMMERMAN & K. MIKULE. 2005. Centrosome control of the cell. cycle. Trends Cell Biol. 15: 303-311.
17. VINCENT, I., M. ROSADO & P. DAVIES. 1996. Mitotic mechanisms in Alzheimer's disease? J. Cell. Biol. 132: 413-425.
18. ROGAEV, E.I., R. SHERRINGTON, E.A. ROGAEVA, et al. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778.
19. DENG, G., J.H. SU & C.W. COTMAN. 1996. Gene expression of Alzheimer-associated presenilin-2 in the frontal cortex of Alzheimer and aged control brain. FEBS Lett. 394: 17-20.
20. DAS, S. & H. POTTER. 1995. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14: 447-456.
21. RUSSO, C., V. DOLCINI, S. SALIS, et al. 2002. Signal transduction through tyrosine-phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. J. Biol. Chem. 277: 35282-35288.
22. VENEZIA, V., C. RUSSO, E. REPETTO, et al. 2004. Apoptotic cell death influences the signaling activity of the amyloid precursor protein through ShcA and Grb2 adaptor proteins in neuroblastoma SH-SY5Y cells. J. Neurochem. 90: 1359-1370.